4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

Biotechnology

Healthcare
$10.79 +1.70%

+$0.16 today

Market cap
$596.08M
Beta
2.76
P/E (TTM)
-4.0
EPS (TTM)
-$2.36
52W Low $3.68High $12.34

Volume 0.81M

Average 0.77M

Price history

4D Molecular Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+6.94%

Period high

$16.76

Period low

$7.19

Latest

$10.79

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
SC 13GNov 10, 2026Nov 10, 2026
4Oct 20, 2026Oct 20, 2026
4Oct 7, 2026Oct 7, 2026
8-KSep 28, 2026Sep 28, 2026
4Sep 22, 2026Sep 22, 2026
4Sep 16, 2026Sep 16, 2026
4Sep 3, 2026Sep 3, 2026
4Aug 21, 2026Aug 21, 2026
4Aug 17, 2026Aug 17, 2026
8-KAug 13, 2026Aug 13, 2026
10-QAug 13, 2026Aug 13, 2026
4Aug 5, 2026Aug 5, 2026
4Aug 4, 2026Aug 4, 2026

Competitors

Who does 4D Molecular Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about FDMT's filings, answered from its disclosures.

What is the latest FDMT filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does FDMT have?

Intrinsic Alpha currently shows 20 recent filings for FDMT.